Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Lescol
Active Ingredient: Fluvastatin sodium 21.06mg equivalent to fluvastatin 20mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Farmaceutica SA, Barcelona, Spain
   
Product: Lescol
Active Ingredient: Fluvastatin sodium 42.12mg equivalent to fluvastatin 40mg
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Farmaceutica SA, Barcelona, Spain
   
Product: Lescol XL
Active Ingredient: Fluvastatin sodium 84.24mg equivalent to fluvastatin 80mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Pfizer Ireland Pharmaceuticals, Newbridge, Ireland


Dated this 9th day of August 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).